Yuanta Financial Holding

Yuanta Securities operates as a subsidiary of Yuanta Financial Holding, a comprehensive financial services firm based in Taipei, Taiwan. Established in 1961, Yuanta Financial Holding provides a diverse range of financial products and services, including brokerage, investment banking, asset management, and wealth management. With a workforce of over 8,000 professionals, it serves both retail and institutional clients across Greater China, maintaining its position as the largest retail broker in Taiwan. Yuanta Securities also has a notable presence in the institutional securities market in Taiwan and Hong Kong, catering to a wide variety of sectors and clients.

Chun Peng

President

Cheng Sun

Director

4 past transactions

GRAID Technology

Series A in 2022
GRAID Technology Inc. is headquartered in Silicon Valley, California with an R&D center in Taipei, Taiwan, and has been formed by a team that has more than 15 years’ experience in the SDS, ASIC and storage industries. Our extraordinary software & hardware solution has redefined every aspect of an SSD RAID card, and makes GRAID SupremeRAID™ the most powerful and flexible NVMe SSD RAID card in the world.

CloudMile

Series B in 2020
Founded in 2016, CloudMile is a Taiwan-based B2B cloud service provider, offering tailor-made cloud solutions to all scale of business by leveraging the power of big data analysis and machine learning. CloudMile is a Google Cloud Partner and Google Cloud Platform’s (GCP’s) APAC strategic service partner. We specialize in Google Cloud services and growing rapidly across Asia. CloudMile provides professional cloud consulting services and technical support to clients from Taiwan, China, Hong Kong and Southeast Asia.

TOT Biopharm

Series B in 2018
TOT Biopharm Company Limited is a clinical-stage biopharmaceutical firm based in Suzhou, China, focused on the development, manufacture, and marketing of innovative oncology drugs and therapies. Founded in 2010, the company specializes in therapeutic biological products, particularly anti-tumor drugs and specialty medicines. One of its notable products is S-1, an oral medication that combines tegafur, gimeracil, and oteracil potassium, designed to enhance the delivery and efficacy of 5-fluorouracil, a key chemotherapeutic agent. TOT Biopharm is committed to establishing a trusted brand in oncology treatments, with a diverse pipeline that includes monoclonal antibodies and antibody-drug conjugates aimed at improving patient outcomes in cancer care. The company's operations primarily generate revenue in Mainland China.

Ta Chong Bank

Acquisition in 2015
Ta Chong Bank Ltd. provides various banking products and services primarily in Taiwan. The company offers financial products and services, including consumer and mortgage loans, saving products, credit cards, personal finance management services, etc. It also provides factoring receivables, guarantee and finance management services, financial products marketing services, fund dispatching and foreign exchange services, derivative financial products, fixed income product investing services, fund and trust management services, etc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.